Morgan Sindall PLC
09 February 2007
TR1: NOTIFICATION OF MAJOR INTERESTS IN SHARES
1 Identity of the issuer or the Morgan Sindall plc
underlying issuer of existing shares
to which voting rights are attached:
2 Reason for the notification: Restatement of historic interest in compliance with the
FSA's new Disclosure and Transparency Rules ('DTR') DTR 5
3 Full name of person(s) subject to Aviva plc & its subsidiaries
the notification obligation:
4 Full name of shareholders(s): Registered holder:
BNY Norwich Union Nominees Limited 485,332*
Chase GA Group Nominees Limited 1,113,160*
Chase Nominees Limited 98,154*
CUIM Nominee Limited 387,335*
Kadoorie McAuley International
Limited 48,900*
* denotes direct interest
BNY Norwich Union Nominees Limited 148,187
Chase Nominees Limited 43,922
CUIM Nominee Limited 36,539
Vidacos Nominee Limited 697,878
DLI Sustainable Futures Fund 19,019
5 Date of the transaction and date on N/A
which the threshold is crossed or
reached:
6 Date on which issuer notified: 8 February 2007
7 Threshold(s) that is/are crossed or N/A
reached:
8 Notified details:
A: Voting rights attached to shares
Class/type of Situation previous to the triggering transaction
shares If possible
using the ISIN code
Number of shares Number of voting rights
N/A N/A N/A
Class/type of Resulting situation after the triggering transaction
shares If possible
using the ISIN code
Number of shares Number of voting rights % of voting rights
Direct Indirect Direct Indirect
Ordinary
GB0008085614 3,078,426 2,132,881 945,545 5.02% 2.22%
B: Financial instruments
Resulting situation after the triggering transaction
Type of financial Expiration Exercise/Conversion Number of voting % of voting rights
instrument date rights that may be
Period/Date acquired if the
instrument is
exercised/converted
N/A
Total (A+B)
Number of voting rights % of voting rights
3,078,426 7.24%
9 Chain of controlled undertakings See section 4
through which the voting rights and/or
the financial instruments are
effectively held, if applicable:
Proxy Voting:
10 Name of the proxy holder:
11 Number of voting rights proxy holder
will cease to hold:
12 Date on which proxy holder will cease
to hold voting rights:
13 Additional information:
14 Contact for further information: Mary Nettleship
15 Contact telephone number: 020 7307 9218
Annex to Notification of Major Interests in Shares
A: Identity of the person or legal entity subject to the notification obligation
Full name (including legal form for legal Aviva plc &its subsidiaries
entities)
Contact address (registered office for legal Aviva plc
entities) PO Box 89
Surrey Street
Norwich
NR1 3DR
Phone number
Other useful information (at least legal
representative for legal persons)
B: Identity of the notifier, if applicable
Full name Mary Nettleship
Contact address Morgan Sindall plc
77 Newman Street
London
W1T 3EW
Phone number 020 7307 9218
Other useful information (eg functional Company Secretary
relationship with the person or legal entity
subject to the notification obligation)
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.